Total Payments
$12,315
2024 Payments
$720.04
Companies
40
Transactions
543
Medicare Patients
6,076
Medicare Billing
$408,498
Payment Breakdown by Category
Food & Beverage$12,198 (99.1%)
Education$116.76 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,198 | 541 | 99.1% |
| Education | $116.76 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,638 | 79 | $0 (2024) |
| Lilly USA, LLC | $1,013 | 49 | $0 (2024) |
| PFIZER INC. | $989.72 | 60 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $968.55 | 47 | $0 (2024) |
| GENZYME CORPORATION | $860.40 | 32 | $0 (2024) |
| Janssen Biotech, Inc. | $805.53 | 44 | $0 (2023) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $667.47 | 33 | $0 (2024) |
| Amgen Inc. | $644.18 | 29 | $0 (2024) |
| Celgene Corporation | $564.30 | 17 | $0 (2019) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $563.89 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $720.04 | 36 | ABBVIE INC. ($156.43) |
| 2023 | $1,315 | 55 | Verrica Pharmaceuticals Inc. ($183.68) |
| 2022 | $1,273 | 51 | ABBVIE INC. ($283.70) |
| 2021 | $1,186 | 61 | Ortho Dermatologics, a division of Bausch Health US, LLC ($185.91) |
| 2020 | $1,159 | 47 | AbbVie Inc. ($207.33) |
| 2019 | $2,453 | 107 | AbbVie, Inc. ($363.34) |
| 2018 | $2,031 | 90 | Lilly USA, LLC ($227.99) |
| 2017 | $2,177 | 96 | AbbVie, Inc. ($263.74) |
All Payment Transactions
543 individual payment records from CMS Open Payments — Page 2 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: IMMUNOLOGY | ||||||
| 03/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.20 | General |
| Category: IMMUNOLOGY | ||||||
| 03/07/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: DERMATOLOGY | ||||||
| 02/21/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: Immunology | ||||||
| 02/14/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $38.79 | General |
| 02/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Dermatology | ||||||
| 02/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: Immunology | ||||||
| 01/30/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: Dermatology | ||||||
| 01/23/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Immunology | ||||||
| 01/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.31 | General |
| Category: IMMUNOLOGY | ||||||
| 01/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.48 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2023 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $31.80 | General |
| Category: DERMATOLOGY | ||||||
| 12/19/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Dermatology | ||||||
| 11/28/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: Dermatology | ||||||
| 11/16/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Immunology | ||||||
| 11/15/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 11/14/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.69 | General |
| Category: Immunology | ||||||
| 11/08/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: Immunology | ||||||
| 10/21/2023 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $151.88 | General |
| Category: DERMATOLOGY | ||||||
| 10/19/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: Inflammation | ||||||
| 10/11/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: DERMATOLOGY | ||||||
| 10/05/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $109.07 | General |
| Category: Dermatology | ||||||
| 09/27/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Dermatology | ||||||
| 09/19/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Immunology | ||||||
| 09/19/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $3.04 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,164 | 2,198 | $410,045 | $84,369 |
| 2022 | 13 | 1,360 | 2,463 | $474,610 | $100,369 |
| 2021 | 12 | 1,686 | 3,135 | $574,633 | $120,878 |
| 2020 | 15 | 1,866 | 3,046 | $375,235 | $102,882 |
Total Patients
6,076
Total Services
10,842
Medicare Billing
$408,498
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 354 | 451 | $87,945 | $26,268 | 29.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 259 | 365 | $109,500 | $13,974 | 12.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 137 | $30,825 | $10,929 | 35.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 108 | 130 | $45,500 | $8,878 | 19.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 52 | 56 | $19,600 | $4,659 | 23.8% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 15 | 15 | $14,250 | $4,389 | 30.8% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 16 | 16 | $28,000 | $4,376 | 15.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 163 | 904 | $45,200 | $4,372 | 9.7% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 22 | 24 | $12,000 | $2,246 | 18.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 49 | 59 | $8,850 | $2,207 | 24.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $4,000 | $1,109 | 27.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 21 | 25 | $4,375 | $961.46 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 422 | 524 | $102,180 | $30,554 | 29.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 299 | 404 | $121,200 | $15,429 | 12.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 105 | 171 | $38,475 | $14,346 | 37.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 139 | 158 | $55,300 | $11,369 | 20.6% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2022 | 15 | 17 | $16,150 | $4,986 | 30.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 194 | 980 | $49,000 | $4,914 | 10.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 48 | 51 | $17,850 | $4,370 | 24.5% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2022 | 13 | 13 | $22,750 | $3,989 | 17.5% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 24 | 30 | $15,000 | $3,066 | 20.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 12 | 12 | $13,980 | $2,190 | 15.7% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2022 | 11 | 14 | $8,400 | $1,860 | 22.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 46 | 50 | $7,500 | $1,791 | 23.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 32 | 39 | $6,825 | $1,505 | 22.0% |
About Dr. Joseph Newmark, M.D
Dr. Joseph Newmark, M.D is a Dermatology healthcare provider based in Vestal, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1902939317.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Newmark, M.D has received a total of $12,315 in payments from pharmaceutical and medical device companies, with $720.04 received in 2024. These payments were reported across 543 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($12,198).
As a Medicare-enrolled provider, Newmark has provided services to 6,076 Medicare beneficiaries, totaling 10,842 services with total Medicare billing of $408,498. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Vestal, NY
- Active Since 03/14/2007
- Last Updated 03/11/2011
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902939317
Products in Payments
- EUCRISA (Drug) $973.43
- TALTZ (Drug) $896.33
- COSENTYX (Biological) $691.41
- Tremfya (Drug) $609.94
- SKYRIZI (Biological) $530.88
- Enbrel (Biological) $512.85
- Humira (Biological) $493.68
- Otezla (Drug) $477.64
- SILIQ (Drug) $444.80
- DUPIXENT (Drug) $440.26
- DUPIXENT (Biological) $402.59
- OPZELURA (Drug) $346.23
- ILUMYA (Biological) $276.30
- Cimzia (Drug) $268.24
- STELARA (Biological) $261.83
- TREMFYA (Drug) $249.89
- COSENTYX (Drug) $237.08
- REMICADE (Biological) $214.84
- RINVOQ (Biological) $185.16
- YCANTH (Drug) $183.68
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Vestal
Dr. Colleen Crandell, D.o, D.O
Dermatology — Payments: $5,503
Dermatology $5,503
Romeo Morales, Md, MD
Dermatology — Payments: $3,061
Dermatology $3,061
Ayyaz Shah, Do, DO
Dermatology — Payments: $1,617
Dermatology $1,617
Shelly Rivas, M.d, M.D
Dermatology — Payments: $1,371
Dermatology $1,371
Dr. Uzoma Oranu, M.d, M.D
Dermatology — Payments: $992.30
Dermatology $992.30
Catalina Dailey, Fnp-C, FNP-C
Dermatology — Payments: $427.62
Dermatology $427.62